Linker
The ideal linker remains stable in the circulatory system and releases the toxin in the tumor. In the design of XDC drugs, a balance between XDC stability and payload release efficiency is achieved by adjusting important linker parameters such as coupling chemistry, linker length, and steric resistance to achieve the desired therapeutic effect of XDC drugs.
- Alkyne PEG
- Amino PEG
- Aminooxy PEG
- ADC Linkers
- BCN-PEG
- Benzyl-PEG
- Biotin PEG
- Bis-PEG-acid
- Bis-PEG-NHS
- Boc-PEG
- Branched PEG
- Bromo PEG
- Cleavable Linkers
- DBCO PEG
- Diketone Linkers
- DNP-PEG
- DOTA PEG
- DSPE PEG
- Fmoc PEG
- Hydroxy PEG
- Lipid PEG
- Maleimide Linkers
- MeNH-PEG
- m-PEG
- Non-PEG linker
- PEG Acid
- PEG Aldehyde
- PEG Azide
- PEG NHS ester
- PEG PFP ester
- PEG Phosphonate
- PEG Silane
- PEG Sulfonic acid
- PEG Tosylate
- PEG-X-PEG
- Peptide Linkers
- Poly PEG
- Propargyl PEG
- PROTAC Linkers
- Sugar PEG
- TCO-PEG
- Tetrazine-PEG
- Fluorescent Reagents
- Thiol PEG
- Ligand-Linker Conjugates
- Other Linker